Knowledge, Attitude, and Practice About Pharmacovigilance Among Healthcare Providers of a Tertiary Care Teaching Hospital in New Delhi (India)

by Monika Agarwal, Jamshed Ahmed, Vandana Roy
Published 2017-01-01

Sistema de Farmacovigilância do Ceará: um ano de experiência Ceará State Pharmacovigilance System: a year of experience

by Helena Lutéscia Coêlho, Paulo Sérgio Dourado Arrais, Adriana Parente Gomes
Published 1999-09-01

Pharmacovigilance as a tool for safety and monitoring: a review of general issues and the specific challenges with end-stage renal failure patients

by Jacob D, Marron B, Ehrlich J, Rutherford PA
Published 2013-04-01

A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis.

by Masakazu Fujiwara, Yohei Kawasaki, Hiroshi Yamada
Published 2016-01-01

Pharmacovigilance in epileptic patients using antiepileptic drugs Farmacovigilância em pacientes com epilepsia em uso de drogas antiepilépticas

by Paulo Afonso Mei, Maria Augusta Montenegro, Marilisa M. Guerreiro, Carlos A.M. Guerreiro
Published 2006-06-01

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting

by Schlienger Raymond, Lengeler Christian, Migoha Christopher, Malila Aggrey, Mulure Nathan, Kabanywany Abdunoor, Genton Blaise
Published 2010-10-01

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting

by Kabanywanyi Abdunoor M, Mulure Nathan, Migoha Christopher, Malila Aggrey, Lengeler Christian, Schlienger Raymond, Genton Blaise
Published 2010-07-01

Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study

by Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Ettore Marconi, Antonio Vitiello, Roberto Bonaiuti, Anna Maria Calvani, Stefano Masi, Ersilia Lucenteforte, Alessandro Mugelli, Lisa Giovannelli, Alfredo Vannacci
Published 2018-04-01

Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases

by Abdulrhman Alrowily, Zahraa Jalal, Mohammed H. Abutaleb, Nermin A. Osman, Maha Alammari, Vibhu Paudyal
Published 2021-10-01

Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database

by Zhuo Ma, Jie Pei, Ximu Sun, Lihong Liu, Wenchao Lu, Qixiang Guo, Jiayou Lyu, Yuwei Liu, Yuhui Zhang, Zhixia Zhao
Published 2021-07-01

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database

by Louis Létinier, Louis Létinier, Amandine Ferreira, Alexandre Marceron, Marina Babin, Joëlle Micallef, Joëlle Micallef, Ghada Miremont-Salamé, Ghada Miremont-Salamé, Antoine Pariente, Antoine Pariente, on behalf of the French Network of Pharmacovigilance Centres
Published 2021-03-01

Bir eğitim hastanesinde farmakovijilans merkezine yönlendirilen yatan hastalardaki advers ilaç reaksiyonlarının analizi

by Zakir Khan, Emine Öz, Olcay Kıroğlu, Yusuf Karataş
Published 2020-06-01

La formation des professionnels de santé pour une efficience de la pharmacovigilance : une analyse juridique d'un système en manque de pédagogie

by Guerriaud, Mathieu
Published 2014

Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments

by Giada Crescioli, Ennio Boscia, Alessandra Bettiol, Silvia Pagani, Giulia Spada, Giuditta Violetta Vighi, Roberto Bonaiuti, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Niccolò Lombardi, on behalf of the MEREAFaPS Study Group
Published 2021-07-01

Respiratory concerns of gabapentin and pregabalin: What does it mean to the pharmacovigilance...

by Sunil Shrestha, Subish Palaian
Published 2021-02-01

A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily

by Chiara Nasso, Anna Mecchio, Michelangelo Rottura, Mariella Valenzise, Francesca Menniti-Ippolito, Paola Maria Cutroneo, Violetta Squadrito, Francesco Squadrito, Giovanni Pallio, Natasha Irrera, Vincenzo Arcoraci, Domenica Altavilla
Published 2020-07-01

Acute Renal Failure in a Patient with Rivaroxaban-Induced Hypersensitivity Syndrome: A Case Report with a Review of the Literature and of Pharmacovigilance Registries

by Gisela Marcelino, Ould Maouloud Hemett, Eric Descombes
Published 2020-01-01

Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)

by Niccolò Lombardi, Giada Crescioli, Alessandra Bettiol, Marco Tuccori, Marco Tuccori, Annalisa Capuano, Roberto Bonaiuti, Alessandro Mugelli, Mauro Venegoni, Giuseppe Danilo Vighi, Alfredo Vannacci, Alfredo Vannacci, the MEREAFaPS Study group, Maria Luisa Aiezza, Alessandra Bettiol, Daria Bettoni, Corrado Blandizzi, Roberto Bonaiuti, Valentina Borsi, Annalisa Capuano, Errica Cecchi, Irma Convertino, Giada Crescioli, Martina Del Lungo, Cristina Di Mauro, Gabriella Farina, Sara Ferraro, Annamaria Fucile, Elena Galfrascoli, Elisabetta Geninatti, Linda Giovannetti, Luca Leonardi, Rosa Liccardo, Niccolò Lombardi, Anna Marra, Eleonora Marrazzo, Giovanna Monina, Alessandro Mugelli, Silvia Pagani, Maria Parrilli, Concetta Rafaniello, Francesco Rossi, Marco Rossi, Stefania Rostan, Marco Ruocco, Marita Sironi, Giulia Spada, Liberata Sportiello, Marco Tuccori, Alfredo Vannacci, Mauro Venegoni, Giuditta Violetta Vighi, Giuseppe Danilo Vighi
Published 2020-04-01